- Home
- DRUG vs FLXS Comparison
DRUG vs FLXS Comparison
Compare DRUG & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- FLXS
- Stock Information
- Founded
- DRUG 2019
- FLXS 2001
- Country
- DRUG United States
- FLXS United States
- Employees
- DRUG N/A
- FLXS N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- FLXS Home Furnishings
- Sector
- DRUG Health Care
- FLXS Consumer Discretionary
- Exchange
- DRUG Nasdaq
- FLXS Nasdaq
- Market Cap
- DRUG 260.6M
- FLXS 301.5M
- IPO Year
- DRUG N/A
- FLXS N/A
- Fundamental
- Price
- DRUG $39.85
- FLXS $53.10
- Analyst Decision
- DRUG Buy
- FLXS
- Analyst Count
- DRUG 1
- FLXS 0
- Target Price
- DRUG $75.00
- FLXS N/A
- AVG Volume (30 Days)
- DRUG 89.2K
- FLXS 30.7K
- Earning Date
- DRUG 02-11-2025
- FLXS 02-03-2025
- Dividend Yield
- DRUG N/A
- FLXS 1.21%
- EPS Growth
- DRUG N/A
- FLXS N/A
- EPS
- DRUG N/A
- FLXS 2.50
- Revenue
- DRUG N/A
- FLXS $422,156,000.00
- Revenue This Year
- DRUG N/A
- FLXS $7.03
- Revenue Next Year
- DRUG N/A
- FLXS $4.99
- P/E Ratio
- DRUG N/A
- FLXS $21.25
- Revenue Growth
- DRUG N/A
- FLXS 7.53
- 52 Week Low
- DRUG $0.93
- FLXS $17.55
- 52 Week High
- DRUG $79.02
- FLXS $65.87
- Technical
- Relative Strength Index (RSI)
- DRUG 51.96
- FLXS 33.37
- Support Level
- DRUG $34.29
- FLXS $53.12
- Resistance Level
- DRUG $42.47
- FLXS $55.51
- Average True Range (ATR)
- DRUG 3.54
- FLXS 2.42
- MACD
- DRUG -0.04
- FLXS -0.93
- Stochastic Oscillator
- DRUG 61.03
- FLXS 6.65
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.